Currently funded projects

Collaboration with African partners to investigate reasons for different onset age of Type 1 Diabetes in Germany and Ghana

Type 1 Diabetes in Ghana and Germany – Immune pathology of early versus late disease onset and influencing genetic and environmental factors

Institution: Klinik für Allgemeine Pädiatrie, Neonatologie und Kinderkardiologie, Universitätsklinikum Düsseldorf
Applicant: Julia Seyfarth
EKFS funding line: first application

Aufklärung von Netzwerkdefekten bei Depressionen

Molecular mechanisms of genetic predisposition to major depressive disorder

Institution: Institute of Physiology, University of Freiburg
Applicant: Jonas-Frederic Sauer
EKFS funding line: first application

Logo of “Recovery Record”

Efficacy of a therapist-guided smartphone-based intervention to support recovery from bulimia nervosa: a randomized controlled trial (SMART-BN trial)

Institution: University Hospital of Munich (LMU), Department of Psychiatry and Psychotherapy
Applicant: Dr. Dipl. Psych, M.Sc. Sandra Schlegl
EKFS funding line: first application

Geschädigte Darmschleimhaut

Influence of specific diets on intestinal tissue damage after radiotherapy

Institution: Department of Radiation Oncology, Technical University of Munich
Applicant: Dr. med. sci. Julius Clemens Fischer
EKFS funding line: first application

World map illustrating the international report of LRRK2 mutation carriers Legend: Countries are in bold, number of centers involved are indicated underneath and the number of carriers from the initial survey is written (N)

Investigation of age-at-onset genetic modifier loci in LRRK2 parkinsonism

Institution: Institute of Neurogenetics, University of Luebeck
Applicant: Joanne Trinh
EKFS funding line: first application

BsAb directed to PSMA and CD3 recruit T cells against tumor cells (A). To avoid “off target” activation and thus side effects (B), expression of the selected target antigen should be restricted to tumor cells.

Drug substance production of the bispecific PSMAxCD3 antibody CC-1 to enable the conduct of a clinical study in patients with squamous cell carcinoma of the lung

Institution: Klinische Kooperationseinheit Translationale Immunologie, Deutsches Konsortium für Translationale Krebsforschung (DKTK), Deutsches Krebsforschungszentrum (DKFZ), Department für Innere Medizin, Universitätsklinikum Tübingen

Dysregulated NFAT5 in the endometrium could lead to poor vessel development

Role of NFAT5 & impaired endometrial blood vessel development.

Applicant: Dr. Madhuri S. Salker
Institution: University Hospital Tübingen, Women’s Health Research Institute
EKFS funding line: first application

Charlotte Flüh

Does sex have an influence on glioma growth and is this due to the intrinsic properties of the glioma cells or the tissue environment?

Institution: Klinik für Neurochirurgie, Universitätsklinikum Schleswig-Holstein, Campus Kiel
Applicant: Dr. Charlotte Flüh
EKFS funding line: first application

Multiplexed complexome profiling

Multiplexed complexomics to foster routine protein complex profiling in medical research and diagnostics

Institution: Universitätsklinikum Hamburg-Eppendorf
Applicant: Sergio Guerrero-Castillo
EKFS funding line: first application